الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 58 |  |  |
| | | from | 58 | | |
Abstract
Imaging during the primary diagnostic work-up in cervical cancer is critical for accurately assessing tumor extent and metastatic disease, and thus selecting the best therapeutic option; and its role was emphasized even more with the revised FIGO staging. Imaging with TVUS/TRUS and/or MRI is used for pretreatment staging to assess local and distant tumor extension.
Our study was performed on sixty-four patients proved to have cervical cancer by prior cervical biopsy at oncology unit of the Department of Obstetrics and Gynecology of Shatby Maternity university hospital, Alexandria, Egypt.
All the patients were staged according to FIGO criteria and underwent a systematic physical examination (which include bimanual pelvic abdominal speculum and per rectal examination) and gynecological examination under anesthesia. They were subjected to MRI and transvaginal ultrasound examinations. In our study, we used MRI findings as a gold standard tool in staging of cervical cancer.
Pelvic MRI was carried out in Alexandria University Hospital. For this study, the examiner of the MRI had access to the patient history but he was blinded to the FIGO staging and ultrasound finding.
Pelvic transvaginal sonography was performed only for research purposes. The ultrasound examiner had access to the patient’s history but he was blinded to the FIGO staging and MRI finding.
According to the statistic results of our study;
• There was a statistically significant difference between TVUS and MRI results regarding to cervical tumor size.
• There was almost perfect agreement between TVUS and MRI results in detecting uterine body invasion.
• There was almost perfec